Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 176

1.

Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study.

Jo T, Yasunaga H, Yamauchi Y, Mitani A, Hiraishi Y, Hasegawa W, Sakamoto Y, Matsui H, Fushimi K, Nagase T.

ERJ Open Res. 2020 Feb 3;6(1). pii: 00246-2019. doi: 10.1183/23120541.00246-2019. eCollection 2020 Jan.

2.

Renal Effects after Pembrolizumab Treatment for Non-small Cell Lung Carcinoma: A Case Report.

Oki R, Hirakawa Y, Kimura H, Honda K, Hinata M, Abe H, Domoto Y, Tanaka G, Nagase T, Nangaku M.

Intern Med. 2019 Dec 6. doi: 10.2169/internalmedicine.3928-19. [Epub ahead of print]

3.

Integrin α11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence.

Ando T, Kage H, Matsumoto Y, Zokumasu K, Yotsumoto T, Maemura K, Amano Y, Watanabe K, Nakajima J, Nagase T, Takai D.

Cancer Sci. 2020 Jan;111(1):200-208. doi: 10.1111/cas.14257. Epub 2019 Dec 18.

4.

Preoperative intervention with long-acting bronchodilators for the reduction of postoperative pulmonary complications in untreated patients with obstructive lung disease.

Mikami Y, Jo T, Matsuzaki H, Ishimori T, Saito M, Sakamoto Y, Yamauchi Y, Takai D, Yatomi Y, Nagase T.

Clin Respir J. 2020 Feb;14(2):92-101. doi: 10.1111/crj.13105. Epub 2019 Nov 25.

PMID:
31715066
5.

Reference value for expiratory time constant calculated from the maximal expiratory flow-volume curve.

Ikeda T, Yamauchi Y, Uchida K, Oba K, Nagase T, Yamada Y.

BMC Pulm Med. 2019 Nov 11;19(1):208. doi: 10.1186/s12890-019-0976-6.

6.

Activation through toll-like receptor 2 on group 2 innate lymphoid cells can induce asthmatic characteristics.

Ishii T, Muroi M, Horiguchi K, Tanamoto KI, Nagase T, Yamashita N.

Clin Exp Allergy. 2019 Dec;49(12):1624-1632. doi: 10.1111/cea.13490. Epub 2019 Sep 30.

PMID:
31494992
7.

Epithelial Expression of YAP and TAZ Is Sequentially Required in Lung Development.

Isago H, Mitani A, Mikami Y, Horie M, Urushiyama H, Hamamoto R, Terasaki Y, Nagase T.

Am J Respir Cell Mol Biol. 2020 Feb;62(2):256-266. doi: 10.1165/rcmb.2019-0218OC.

PMID:
31486675
8.

Brain Metastasis Mimicking Brain Abscess in ALK-Positive Non-Small-Cell Lung Cancer.

Sakatani T, Kage H, Takayanagi S, Watanabe K, Hiraishi Y, Shinozaki-Ushiku A, Tanaka S, Ushiku T, Saito N, Nagase T.

Case Rep Oncol Med. 2019 Jun 17;2019:9141870. doi: 10.1155/2019/9141870. eCollection 2019.

9.

Pleural thickening on screening chest X-rays: a single institutional study.

Saito A, Hakamata Y, Yamada Y, Sunohara M, Tarui M, Murano Y, Mitani A, Tanaka K, Nagase T, Yanagimoto S.

Respir Res. 2019 Jul 5;20(1):138. doi: 10.1186/s12931-019-1116-9.

10.

Rapid temporal improvement of pembrolizumab-induced pneumonitis using the anti-TNF-α antibody infliximab.

Sawai Y, Katsuya Y, Shinozaki-Ushiku A, Iwasaki A, Fukayama M, Watanabe K, Nagase T.

Drug Discov Ther. 2019 Jul 22;13(3):164-167. doi: 10.5582/ddt.2019.01032. Epub 2019 Jun 28.

11.

Small lung tumor biopsy samples are feasible for high quality targeted next generation sequencing.

Kage H, Kohsaka S, Shinozaki-Ushiku A, Hiraishi Y, Sato J, Nagayama K, Ushiku T, Takai D, Nakajima J, Miyagawa K, Aburatani H, Mano H, Nagase T.

Cancer Sci. 2019 Aug;110(8):2652-2657. doi: 10.1111/cas.14112. Epub 2019 Jun 21.

12.

Leptin enhances cytokine/chemokine production by normal lung fibroblasts by binding to leptin receptor.

Watanabe K, Suzukawa M, Arakawa S, Kobayashi K, Igarashi S, Tashimo H, Nagai H, Tohma S, Nagase T, Ohta K.

Allergol Int. 2019 Sep;68S:S3-S8. doi: 10.1016/j.alit.2019.04.002. Epub 2019 Apr 24.

13.

Naftopidil reduced the proliferation of lung fibroblasts and bleomycin-induced lung fibrosis in mice.

Urushiyama H, Terasaki Y, Nagasaka S, Kokuho N, Endo Y, Terasaki M, Kunugi S, Makita K, Isago H, Hosoki K, Souma K, Ishii T, Matsuzaki H, Hiraishi Y, Mikami Y, Noguchi S, Tamiya H, Mitani A, Yamauchi Y, Shimizu A, Nagase T.

J Cell Mol Med. 2019 May;23(5):3563-3571. doi: 10.1111/jcmm.14255. Epub 2019 Mar 15.

14.

Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.

Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K, Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K, Aburatani H, Mano H.

Cancer Sci. 2019 Apr;110(4):1464-1479. doi: 10.1111/cas.13968. Epub 2019 Mar 5.

15.

Polysomnographic features of low arousal threshold in overlap syndrome involving obstructive sleep apnea and chronic obstructive pulmonary disease.

Yamaguchi Y, Shiota S, Kusunoki Y, Hamaya H, Ishii M, Kodama Y, Akishita M, Kida K, Takahashi K, Nagase T, Fukuchi Y.

Sleep Breath. 2019 Dec;23(4):1095-1100. doi: 10.1007/s11325-019-01786-7. Epub 2019 Jan 26.

PMID:
30685846
16.

Spontaneous Transdifferentiation from Small Cell Lung Carcinoma to Squamous Cell Carcinoma.

Watanabe K, Kage H, Shinozaki-Ushiku A, Kohsaka S, Takai D, Nakajima J, Miyagawa K, Aburatani H, Mano H, Nagase T.

J Thorac Oncol. 2019 Feb;14(2):e31-e34. doi: 10.1016/j.jtho.2018.10.159. No abstract available.

17.

Reduction in exacerbation of COPD in patients of advanced age using the Japanese Kampo medicine Dai-kenchu-to: a retrospective cohort study.

Jo T, Michihata N, Yamana H, Sasabuchi Y, Matsui H, Urushiyama H, Mitani A, Yamauchi Y, Fushimi K, Nagase T, Yasunaga H.

Int J Chron Obstruct Pulmon Dis. 2018 Dec 27;14:129-139. doi: 10.2147/COPD.S181916. eCollection 2019.

18.

Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.

Abe M, Watanabe K, Shinozaki-Ushiku A, Ushiku T, Abe T, Fujihara Y, Amano Y, Zong L, Wang CP, Kubo E, Inaki R, Kinoshita N, Yamashita S, Takai D, Ushijima T, Nagase T, Hoshi K.

BMC Cancer. 2019 Jan 11;19(1):52. doi: 10.1186/s12885-019-5277-1. Review.

19.

IL-33, IL-25 and TSLP contribute to development of fungal-associated protease-induced innate-type airway inflammation.

Hiraishi Y, Yamaguchi S, Yoshizaki T, Nambu A, Shimura E, Takamori A, Narushima S, Nakanishi W, Asada Y, Numata T, Suzukawa M, Yamauchi Y, Matsuda A, Arae K, Morita H, Hoshino T, Suto H, Okumura K, Matsumoto K, Saito H, Sudo K, Iikura M, Nagase T, Nakae S.

Sci Rep. 2018 Dec 21;8(1):18052. doi: 10.1038/s41598-018-36440-x.

20.

Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab.

Noda-Narita S, Mizuno S, Noguchi S, Watanabe K, Nakai Y, Koike K, Kage H, Nagase T.

Eur J Cancer. 2019 Jan;107:93-96. doi: 10.1016/j.ejca.2018.11.021. Epub 2018 Dec 13. No abstract available.

PMID:
30554074

Supplemental Content

Loading ...
Support Center